Navigation Links
Clarient Names Michael J. Pellini, M.D. Chief Operating Officer
Date:10/4/2007

the Company's ability to maintain compliance with financial and other covenants under its credit facilities, the continuation of favorable third party payer reimbursement for laboratory tests, unanticipated expenses or liabilities or other adverse events affecting cash flow, uncertainty of success in identifying and developing new diagnostic tests or novel markers, failure to obtain FDA clearance or approval for particular applications, the Company's ability to compete with other technologies and with emerging competitors in novel cancer diagnostics and dependence on third parties for collaboration in developing new tests, and risks detailed from time to time in the Company's SEC reports, including quarterly reports on Form 10-Q, reports on Form 8-K and annual reports on Form 10-K. Recent experience with respect to laboratory services, revenues and results of operations may not be indicative of future results for the reasons set forth above.

The company does not assume any obligation to update any forward-looking statements or other information contained in this document.

Contact:

Matt Clawson John Baldissera

Allen & Caron, Inc. BPC Financial Marketing

(949) 474-4300 (800) 368-1217

matt@allencaron.com


'/>"/>
SOURCE Clarient, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Vietnamese Scientists Unravel Genetic Code Of Bird Flu Virus
2. Financial Allowances Being Offered To Poor Vietnamese HIV Carriers
3. Gene Bias: Onomastics of Shared Surnames among Men Reveals Genetic links
4. AIDS Funding Grants Dependant on Tracking Patients Names Efficiently
5. Health Minister Wants Names of Uncooperative Hospital Consultants
6. Chinese PLA Names Bogus Army Medical Bodies Selling Fake Drugs
7. Over 50 Vietnamese Girls Faint Due to Mass Hysteria
8. All U.S. States To Begin Names-Based Reporting of HIV Cases by End of 2007
9. Rajasthan Directs Doctors to Prescribe Medicines by Generic Names
10. Gest Says Will Reveal Damning Secrets On Michael Jackson
11. Ask Right Questions and Save Country from Further Healthcare Crisis: Michael Moore
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...alth System say the federal government could promo...ive manner that would ultimately save lives. They ...rt a Flu vaccination programme, //by direct advert...cal companies. They are hoping to target individu...
...BCC-5) had doctors, nurses, patients and advocates...ient care//. Breast cancer is the most common canc...l rates are improving. The event was conducted by...th each other. The European Breast Cancer Coalitio...
...becoming apparent to the Government Health officia...is now pulling up// its socks and gearing up to ta...s, or directly observed treatment, short-course, a...by the World Health Organization and its partners,...
... noted in Europe, following the reduction in numbe...hift of the media coverage // to other important s...ion of consumer fears about bird flu. Although p...resent a pathetic picture, the overall situation s...
Other Medicine News:Health News:Influenza Vaccination For The Elderly 2
(Date:10/7/2008)... 7 /- A study published in the,scient...self-renewal,reported that InVitria,s ( http://ww...m albumin) was an effective replacement to bovine ...titled, "The ground state of embryonic stem cell,s...astim as a recombinant,albumin in place of animal-...
(Date:10/7/2008).../- Aerovance Inc. today reported,phar...ial of its Aerovant,inhalation powder that demonst...rritancy following asthma patients, inhalation of ... highest of three doses investigated in,Aerovance,... to begin early,next year. Evidence gathered from ...
(Date:10/7/2008)...wire-FirstCall/ -- Ardea Biosciences, Inc.,(Nasdaq...RDEA119, a Potent,and Highly Selective MEK1/2 Inhi...) -- induced Chronic Colitis in Mice," was present...G) 2008 Annual Meeting in Orlando,Florida. The po... of,RDEA119, the Company,s lead mitogen-activated ...
(Date:10/7/2008)...ber 7 /-, - 125 Patient, P...Study,Shows Statistically Significant Improved Ove...the mature phase II data from the,therapeutic pros...d been,obtained as part of the recently entered pa... in the US., The results from the Phase II prospe...
Breaking Medicine Technology:Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 5Sorafenib Shows Promise for Heart Lung Disease 19870 1Sorafenib Shows Promise for Heart Lung Disease 19870 2SleepQuest Holds Open House 19866 1SleepQuest Holds Open House 19866 2Caraco Pharmaceutical Laboratories Ltd to Announce Fourth Quarter and Fiscal Year 2008 Results on May 29 2008 19861 1Caraco Pharmaceutical Laboratories Ltd to Announce Fourth Quarter and Fiscal Year 2008 Results on May 29 2008 19861 2Hepatitis B Foundation and AAPCHO Sponsor Congressional Briefing on Zero Tolerance for Hepatitis B 5537 1Hepatitis B Foundation and AAPCHO Sponsor Congressional Briefing on Zero Tolerance for Hepatitis B 5537 2
...--May 29, 2007 - Introgen,Therapeutics, Inc. (NASD...will report updated Phase 2 clinical trial results... the upcoming,annual meetings of The American Soci... American Society of Gene Therapy (ASGT) in,Seattl...ine of,first-in-class cancer therapies generating ...
...29, 2007 - Mitopharm Corporation,Inc. (Pink Sheet...where Professor Dr. Robert Ko published the benefi...) Schisandrin B - a novel,discovery by Dr. Ko - on...tled "SCHISANDRIN B PROTECTS AGAINST,MYOCARDIAL IS...GLUTATHIONE ANTIOXIDANT STATUS"; Yim and Ko; Molec...
Other Medicine Technology:Introgen and Clinical Collaborators to Report New Results with,Advanced-Stage Cancer Therapies at Upcoming Medical Meetings 2Introgen and Clinical Collaborators to Report New Results with,Advanced-Stage Cancer Therapies at Upcoming Medical Meetings 3Investigation Findings, Corroborated by Empirical Evidence of the,Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine,for Hundreds of Years, Support the Use of Schisandrin B in the,Prevention and Treatment of IHD 2Investigation Findings, Corroborated by Empirical Evidence of the,Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine,for Hundreds of Years, Support the Use of Schisandrin B in the,Prevention and Treatment of IHD 3
Features soft, low friction sheath that extends beyond the tip.
Designed to retain the desired curve during oral intubation.
Facilitates intubation of tracheal tubes.
SunGlide™ Stylette - Grey Child. Use in 4.0 to 7mm tubes. 25/box.
Medicine Products: